Global Prothrombin Time Testing Market – Industry Trends - Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Jun 2019
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Prothrombin Time Testing Market By Product (Instruments, Consumables, Systems), Application (TT, PTT, aPTT, PT, Others), Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, Others), End-Users (Diagnostic Laboratories, Hospitals, Clinical Laboratories, POCT, Home Care Settings, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Prothrombin Time Testing Market

Global prothrombin time testing market is expected to register a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the growth in easier availability of products online along with advancements in technologies resulting in better designed products.

Market Definition: Global Prothrombin Time Testing Market

Prothrombin time testing is a specialized blood test which is used to measure the effectiveness of plasma present in the blood, specifically measuring how long it takes for the blood clotting process. This test helps in identifying any underlying conditions present with the patients relating to the blood as well as measuring the effectiveness of therapeutics which help resolve the problem of blood clotting.

Market Drivers

  • Increasing levels of geriatric population which are more prone to suffer from cardiovascular disorders and blood; this factor is expected to drive the growth of the market
  • Increased usage of POCT products and homecare products; this factor is expected to drive the growth of the market
  • Rise in the levels of awareness regarding the benefits and effectiveness of these products for detecting the blood disorders is expected to drive the growth of the market

Market Restraints

  • Presence of strict regulations and compliances that result in a time-consuming, complicated approval process; this factor is expected to restrain the growth of the market
  • Significant costs associated with the advanced levels of devices in combination with the lack of skilled professionals; this factor is expected to restrain the market growth

Segmentation: Global Prothrombin Time Testing Market

By Product

  • Point-Of-Care Testing (POCT) Systems
  • Instruments
  • Consumables

    • Reagents
    • Standards
    • Controls & Calibrations

  • Systems

    • Automated
    • Manual
    • Semi-Automated

By Application

  • Thrombin Time (TT)
  • Partial Thromboplastin Time (PTT)
  • Activated Partial Thromboplastin Time (aPTT)
  • Prothrombin Time (PT)
  • Others

By Technology

  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
  • Others

By End-Users

  • Diagnostic Laboratories
  • Hospitals
  • Clinical Laboratories
  • Point-Of-Care Testing
  • Home Care Settings
  • Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Argentina
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • Middle East & Africa

    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In March 2019, ARKRAY, Inc. announced the launch of their blood coagulation testing product. The product designed to provide quick and efficient analysis in the surgical sites utilizing whole blood samples. The product termed as “SPOTCHEM HS HS-7710” is a fully automated blood coagulation analyzer is the first foray of the organization into blood analysis in the surgical applications.
  • In June 2018, Hoffmann-La Roche Ltd announced the launch of their homecare settings coagulation testing system, named as “CoaguChek Vantus” system. The system is a wireless-system which provides the results of a self-administered test conducted by patients for measuring the effectiveness of blood thinners in patients and sending this data to the healthcare providers.

Competitive Analysis: Global Prothrombin Time Testing Market

Global prothrombin time testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of prothrombin time testing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Prothrombin Time Testing Market

Few of the major competitors currently working in the global prothrombin time testing market are Sysmex Corporation; Medtronic; F. Hoffmann-La Roche Ltd; Abbott; Micropoint Biosciences; ARKRAY, Inc.; NIHON KOHDEN CORPORATION; Diagnostica Stago S.A.S.; Thermo Fisher Scientific; Helena Laboratories; Siemens Healthcare GmbH; SEKISUI MEDICAL CO., LTD.; Coagulation Sciences LLC; Universal Biosensors; HemoSonics, LLC; Beckman Coulter, Inc.; Instrumentation Laboratory Company; Grifols, S.A.; BD; Bio/Data Corporation and Chrono-log Corporation.

Research Methodology: Global Prothrombin Time Testing Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global prothrombin time testing market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19